Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
April 08, 2022 at 12:15 PM EDT
A Conshohocken firm received approval for a cancer therapy from the European Commission.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.